journal article·2024-11

ICAM‐1‐Expressing Extracellular Vesicles Enable Sequential Delivery Barrier‐Breaking and Microenvironment Modulating for Glioblastoma Stem Cell Inhibition

Fuming Liang, Qing You, Huayi Wang, Jingyi Liu, Qiwei Yang, Di Lu, Xiaopeng Ma, Chen Wang, Zhaohui He, Yanlian Yang, Ling Zhu

Advanced Functional Materials· Volume 34· Issue 46
Publisher page

Abstract

Abstract Glioma stem‐like cell (GSC) inhibition is a promising strategy for glioblastoma therapy. However, it is hampered by two main obstacles: first, delivery barriers, including the blood–brain barrier (BBB) and deep tumor‐penetrating obstacles, hinder sufficient drug accumulation in GSCs that often reside in hypoxic niches deep in glioblastoma; second, hypoxia and the immunosuppressive tumor microenvironment (TME) limit the therapeutic responses of GSC inhibition strategies. An intercellular cell adhesion molecule 1 (ICAM‐1)‐expressing M1 macrophage‐derived small extracellular vesicles loaded with a complex of bovine serum albumin, MnO2, and the small‐molecule inhibitor PTC209 (IsEV‐BMP) is constructed to achieve sequential barrier‐breaking delivery and simultaneous TME modulation to boost GSC inhibition. ICAM‐1 facilitates endothelial transcytosis‐mediated BBB crossing, microglial transcytosis‐mediated deep tumor penetration, and internalization of IsEV‐BMPs in GSCs. Hypoxia alleviation inhibits the binding of hypoxia‐inducible factor 1α (HIF‐1α) to hypoxia‐responsive elements on the gene promoters of cancer stem cell‐related markers and CD47 in GSCs, thereby improving PTC209 sensitivity and immune phagocytosis of GSCs. IsEV‐BMP achieves simultaneous microglial polarity transition and immuno‐microenvironmental modulation during microglial transcytosis‐mediated deep tumor penetration. This study provides a strategy to overcome the sequential delivery barrier for effective glioblastoma treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory of Standardization and Measurement for Nanotechnology CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 P. R. China

Department of Neurosurgery The First Affiliated Hospital of Chongqing Medical University 1 Friendship Road Chongqing 400016 P. R. China

University of Chinese Academy of Sciences Beijing 100049 P. R. China

Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering Biomedical Engineering Yong Loo Lin School of Medicine and Faculty of Engineering National University of Singapore Singapore 119074 P. R. China

Department of Orthopaedic Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 P. R. China

Department of Breast Surgery The First Affiliated Hospital of University of Science and Technology of China Hefei Anhui 230001 P. R. China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (70)

Show source-provided references
1. 10.1016/S0140-6736(23)01054-110.1016/S0140-6736(23)01054-1 ↗
2. 10.1038/s41392-023-01481-w10.1038/s41392-023-01481-w ↗
3. 10.1038/s41596-021-00634-x10.1038/s41596-021-00634-x ↗
4. 10.1073/pnas.210328011810.1073/pnas.2103280118 ↗
5. 10.1002/advs.20210109010.1002/advs.202101090 ↗
6. 10.1038/s41467-018-03705-y10.1038/s41467-018-03705-y ↗
7. 10.1038/s41573-021-00139-y10.1038/s41573-021-00139-y ↗
8. 10.1586/14737140.6.8.118710.1586/14737140.6.8.1187 ↗
9. 10.1038/nrc145610.1038/nrc1456 ↗
10. 10.1038/nbt.333010.1038/nbt.3330 ↗
11. 10.1038/nature0523610.1038/nature05236 ↗
12. 10.1016/j.stem.2014.01.00510.1016/j.stem.2014.01.005 ↗
13. 10.1101/gad.261982.11510.1101/gad.261982.115 ↗
14. 10.1016/j.trecan.2015.10.00910.1016/j.trecan.2015.10.009 ↗
15. 10.1093/neuonc/now25810.1093/neuonc/now258 ↗
16. 10.1016/j.bbcan.2018.04.00810.1016/j.bbcan.2018.04.008 ↗
17. 10.1038/s41565-019-0485-z10.1038/s41565-019-0485-z ↗
18. 10.1073/pnas.101838210810.1073/pnas.1018382108 ↗
19. 10.1038/s41563-022-01251-z10.1038/s41563-022-01251-z ↗
20. 10.1038/s41565-019-0485-z10.1038/s41565-019-0485-z ↗
21. 10.1186/s12935-020-01729-310.1186/s12935-020-01729-3 ↗
22. 10.1016/j.stem.2017.10.00510.1016/j.stem.2017.10.005 ↗
23. 10.1073/pnas.152003211210.1073/pnas.1520032112 ↗
24. 10.1038/s44222-022-00004-610.1038/s44222-022-00004-6 ↗
25. Wang L. T. W. · Cancer Cell · 2024 · 42
26. 10.1038/s41590-023-01605-y10.1038/s41590-023-01605-y ↗
27. 10.1038/nn.418510.1038/nn.4185 ↗
28. 10.1038/s41467-021-21407-w10.1038/s41467-021-21407-w ↗
29. 10.1002/adma.20230658310.1002/adma.202306583 ↗
30. 10.1126/sciadv.adi364710.1126/sciadv.adi3647 ↗
31. 10.1021/acsnano.9b0439710.1021/acsnano.9b04397 ↗
32. 10.1038/s41467-019-11718-410.1038/s41467-019-11718-4 ↗
33. 10.1002/adfm.20170307410.1002/adfm.201703074 ↗
34. 10.1038/s41467-021-25189-z10.1038/s41467-021-25189-z ↗
35. 10.1016/j.yexcr.2009.11.01510.1016/j.yexcr.2009.11.015 ↗
36. 10.1016/j.jconrel.2012.06.00710.1016/j.jconrel.2012.06.007 ↗
37. 10.1016/j.stemcr.2017.02.00810.1016/j.stemcr.2017.02.008 ↗
38. 10.1038/s41467-021-25189-z10.1038/s41467-021-25189-z ↗
39. 10.1016/j.lfs.2023.12155810.1016/j.lfs.2023.121558 ↗
40. 10.1038/cdd.2011.14010.1038/cdd.2011.140 ↗
41. 10.1039/C9NR01255A10.1039/C9NR01255A ↗
42. 10.1038/onc.2009.25210.1038/onc.2009.252 ↗
43. 10.1186/1471-2407-12-45510.1186/1471-2407-12-455 ↗
44. 10.3390/ijms2406528310.3390/ijms24065283 ↗
45. 10.1073/pnas.063176610010.1073/pnas.0631766100 ↗
46. 10.1002/adma.20160190210.1002/adma.201601902 ↗
47. 10.1002/tcr.20180008510.1002/tcr.201800085 ↗
48. 10.1042/bse057000110.1042/bse0570001 ↗
49. 10.1002/advs.20190003710.1002/advs.201900037 ↗
50. 10.1002/advs.20190003710.1002/advs.201900037 ↗
51. 10.7150/thno.6145210.7150/thno.61452 ↗
52. 10.1016/j.biopha.2020.11062310.1016/j.biopha.2020.110623 ↗
53. 10.1073/pnas.171819711510.1073/pnas.1718197115 ↗
54. 10.3389/fimmu.2018.0174410.3389/fimmu.2018.01744 ↗
55. 10.1016/j.biomaterials.2021.12113710.1016/j.biomaterials.2021.121137 ↗
56. 10.1021/jacs.0c0503910.1021/jacs.0c05039 ↗
57. 10.1002/adma.20200556210.1002/adma.202005562 ↗
58. 10.1016/j.it.2004.09.01510.1016/j.it.2004.09.015 ↗
59. 10.1002/adma.20180721110.1002/adma.201807211 ↗
60. 10.1002/anie.20191252410.1002/anie.201912524 ↗
61. 10.1007/s12015-018-9828-710.1007/s12015-018-9828-7 ↗
62. 10.1038/s41577-018-0029-z10.1038/s41577-018-0029-z ↗
63. 10.1182/blood.201900399010.1182/blood.2019003990 ↗
64. 10.7150/thno.2025110.7150/thno.20251 ↗
65. 10.1038/nature2012310.1038/nature20123 ↗
66. 10.1126/scitranslmed.abn112810.1126/scitranslmed.abn1128 ↗
67. 10.1038/nature1128710.1038/nature11287 ↗
68. 10.1038/nm.441510.1038/nm.4415 ↗
69. 10.1126/scitranslmed.aah681610.1126/scitranslmed.aah6816 ↗
70. 10.1021/acsnano.4c0048010.1021/acsnano.4c00480 ↗